EP0690708A1 - Cosmetic composition - Google Patents
Cosmetic compositionInfo
- Publication number
- EP0690708A1 EP0690708A1 EP94901923A EP94901923A EP0690708A1 EP 0690708 A1 EP0690708 A1 EP 0690708A1 EP 94901923 A EP94901923 A EP 94901923A EP 94901923 A EP94901923 A EP 94901923A EP 0690708 A1 EP0690708 A1 EP 0690708A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition according
- surfactant
- cells
- gas
- gas cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims description 44
- 239000002245 particle Substances 0.000 claims abstract description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
- 239000004094 surface-active agent Substances 0.000 claims description 23
- 239000004615 ingredient Substances 0.000 claims description 15
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims description 2
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 239000003093 cationic surfactant Substances 0.000 claims description 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 91
- 239000007788 liquid Substances 0.000 description 17
- 239000012071 phase Substances 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000006260 foam Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- -1 sucrose mono stearate ester Chemical class 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 238000007323 disproportionation reaction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 230000005653 Brownian motion process Effects 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 2
- 238000005537 brownian motion Methods 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- 239000004358 Butane-1, 3-diol Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical group CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000008350 hydrogenated phosphatidyl choline Substances 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008251 pharmaceutical emulsion Substances 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229940035023 sucrose monostearate Drugs 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Definitions
- This invention relates to cosmetic and pharmaceutical compositions, in particular aerated pastes, creams and lotions intended for topical application to the skin, hair, mucosae and teeth.
- a problem encountered with many products, including cosmetic compositions, containing gas cells is the stability with time: this is because a gas cell dispersion comprising large cells is vulnerable to creaming separation of the dispersion into discrete layers of different gas phase volume, the larger cells in the high gas phase volume layer will coalesce through film rupture, while the smaller gas cells, say under 100 ⁇ m, are unstable with time, due to disproportionation in favour of larger cells and this is in particular true if the gas cells become finer.
- US4,588,582 discloses modifying the appearance of toothpaste by incorporation therein of 10 to 20% of a gas in the form of discrete bubbles having a diameter in the range of from 10 to 30 microns to give stability.
- EP 521 543 describes gas cells dispersed in a continuous liquid medium in a stable condition, ie having a stability in excess of two weeks, the gas cells having a measured d3,2 average diameter of less than 20 ⁇ m.
- the boundary surface of each cell that is the surface separating the gas of each cell and the rest of the product, is preferably structured and comprises a multitude of adjacent domes. Specific stability is obtained if the great majority of the domes have hexagonal and some pentagonal outlines. Usually, some irregularities, for example higher polygons, are present amongst the domed structures. These polygons can be of very irregular shape.
- the regular domed surface is absent and may then be smooth or buckled.
- Gas cells of a good stability with respect to creaming and disproportionation are obtained when the cells have diameters in the range from 0.1 to 20 ⁇ m and more preferably from 0.5 to 3 ⁇ m. Diameter throughout this description and claims refers to a measured d3,2 (volume surface) average diameter.
- liquid medium in this description and claims means any medium showing molecule mobility, ie including gels and viscous liquids.
- a suitable method of preparing a multitude of gas cells in a liquid medium comprises whipping a liquid medium with a gas such that gas cells of the required dimension are formed while having a surface active agent contained in that liquid medium for stabilising the gas cells.
- a gas such that gas cells of the required dimension are formed while having a surface active agent contained in that liquid medium for stabilising the gas cells.
- sufficient shear should be exerted on the larger gas cells that initially are formed. Factors influencing this shear are the type of mixer or beater or whisk, the viscosity of the liquid medium and the temperature thereof.
- a high shear, mixer such as a Kenwood Chef mixer, a colloid mill, an Oakes mixer, a cavity transfer mixer or a Silverson will be used.
- a Kenwood Chef mixer By increasing the viscosity and/or lowering the temperature of the liquid medium the size reducing effect of the mixer on the gas cells is increased.
- a Kenwood Chef mixer is used at room temperature a suitable dynamic viscosity of the liquid medium is preferably from 0.1 Pa.s to 20 Pa.s although the range of from 0.2 to 0.4 Pa.s is preferred.
- this foam is then aged.
- Stable gas, cells may then be separated from part of the liquid medium used for preparing the cells. Separation can be achieved by centrifuging or using a dialysis membrane after modifying the liquid phase of the gas cell suspension such as by dilution with a miscible fluid.
- this gas cells ingredient in the compositions of the invention provides improved creaminess in texture, a whiter more opaque product and, dependent on components, enhanced fragrance, flavour, or improved skin or mouthfeel.
- suspensions of gas cells prepared as described can be used to replace, or improve on, some of the attributes normally contributed by the oil/fat in cosmetic or pharmaceutical emulsions.
- the invention provides a cosmetic or pharmaceutical composition
- a preformed gas cells ingredient comprising a surfactant, in which the gas cells have a d3,2 average particle size of less than 20 ⁇ m and a stability in excess of 2 weeks.
- the invention is founded on the preparation of an ingredient comprising a large number of very stable gas cells of very small size. When such cells are present in bulk they will form about 10 8 to about 10 10 per ml. On incorporation of this ingredient into a cosmetic or pharmaceutical composition, it is preferably distributed throughout the mass in the form of discrete cells so as to provide the benefits associated with their presence. However it must be expected that the cells are lilekly to form flocculates in the composition.
- the stable gas cells whether present in discrete form or as flocculates, are distinguished from any gas cells of a larger size that may be present. The latter is not in the form of stable cells, but contributes most of the volume.
- the gas cell number concentration in the composition will be above about 10 6 per ml, preferably above 10 7 per ml, with the number and size selected to provide the desired benefit.
- the particle size of the gas cells is less than 20 ⁇ m, more preferred 0.1 to 10 ⁇ m, most preferred from 1 to 6 ⁇ m.
- the gas cells ingredient for use in compositions of the invention have a stability in excess of 2 weeks. With this is meant that upon storage for 2 weeks at 4°C more than 90% by number of the gas cells in the composition still remain intact.
- compositions, wherein the stability of the gas cells is more than 4 weeks, most preferably more than 8 weeks.
- the gas cells ingredient can be prepared from a cosmetically acceptable surface active material suitable for the making of gas cells with structured surfaces, that is a surfactant whose head group does not carry a substantial charge, compared to that of an ionised anionic or cationic surfactant, and whose head group also occupies a similar surface area to that of the tail group, such that the tail group is capable of crystallising at the storage temperature of the composition.
- the tail group of the surfactant is saturated and has a carbon chain of at least 14, preferably from 16 to 22 carbon atoms, for products to be held at room temperature or slightly higher.
- Suitable surfactants are nonionic or virtually so in character, for example mono-, di- or tri-long chain fatty acid esters of sucrose or distearoyl or dipalmitoyl phosphatidylcholine or mixtures thereof.
- any suitable thickener may be present in the system while forming the stable gas cells.
- suitable thickener materials are for example sugars, (hydroxy-alkyl) celluloses, hydrolysed starches and mixtures thereof.
- compositions containing the gas cells in accordance to the invention it is desirable to prepare the gas cells in bulk separately and add these as an ingredient to the composition during or after its preparation.
- a suitable method of pre-preparing the gas cells ingredient involves the preparation of an aqueous solution of the desired viscosity (for example by using a thickener material at a suitable level) and containing 0.1 to 20 wt% of surfactant (s).
- surfactant s
- the selection of the surfactant is critical to the subsequent stability of the gas cells. It is restricted to those providing the surface characteristics as described earlier.
- Gas cells are mechanically incorporated into the aqueous solution and then comminuted by suitable agitation, preferably at high shear, until a system is formed wherein the average particle size of the gas cells is within the limits as herein before described.
- gas cells according to the invention can if desired "be manufactured without the use of a separate component to contribute the principal part of the viscosity.
- the cosmetic or pharmaceutical compositions of the invention into which the gas cells are incorporated, as a separate ingredient can be any composition which is suitable for topical application to the skin, hair, mucosae or the teeth.
- the ingredients of such composition in addition to the gas cells will be those that are conventionally employed by manufacturers and formulations of cosmetic and pharmaceutical compositions.
- the gas cells can be employed to enhance delivery, during topical application, of active materials that can benefit the skin, hair, mucosae or teeth.
- co-surfactants containing suitable lipid chains may be incorporated into the structured gas cell surface.
- the co surfactant is molecularly dispersed within the interface.
- the stable gas cells therefore provide a favourable vehicle both to hold and to deposit beneficial surface active species onto a surface.
- beneficial surface active species such as ceramides may be included into and deposited from such structures.
- the gas cells When the composition is in liquid or semi liquid form, the gas cells can be employed to enhance the appearance of the composition.
- gas cells of the present invention scatter light very effectively. Consequently, a concentrated suspension for example, greater than 10 7 cells ml -1 when present in a suitable support medium can be used as a barrier to light radiation.
- Such cells can be used to replace or augment organic sunscreens or solid inorganic pigments, such as ultra fine titanium dioxide, which are currently used in sunscreen creams and lotions.
- the amount of gas cells that can usefully be incorporated into compositions in accordance with the invention, as a preformed gas cells ingredient is from 0.001 to 80%, preferably from 0.1 to 10% by volume of the composition.
- aqueous solution was prepared containing 70% by wt of maltodextrin 63DE and 2% by wt of sucrose mono stearate ester. Using a Kenwood chef mixer this solution was whipped with air for l hour at speed 5. A thick creamy foam resulted.
- This foam showed an air phase volume of 0.6 and the great majority of the gas cells had a diameter of the order of 2 ⁇ m and below. On standing for 40 days little visible change had occurred in these cells.
- Electron microscopy photographs showed (see Figures 1 and 2) that the air cells had surfaces compartmentalised into domes, most of the domes having a hexagonal and some pentagonal outline. Few showed a differently polygonal outline: See in particular, Figure 2.
- a representation showing part of a domed surface and made with the largest magnification factor is shown in Fig 3.
- the foam as prepared could be diluted 1000 times with water resulting in a white milky liquid. The same result was obtained on 1000 times dilution with a 30% by wt aqueous maltodextrin 63DE solution. Though no longer suspended/dispersed in a thick viscous aqueous liquid the gas cells with diameters less than 5-10 ⁇ m remained in suspension, although with some creaming. This creaming could be reversed by simple stirring or swirling. No significant change took place over 20 days.
- the gas cells could be concentrated again to a gas phase volume of 0.4 by centrifuging the diluted liquid in a centrifuge at a speed of 2500 rpm for 5 minutes.
- the rate of concentration of the gas cells by centrifugation could be manipulated by varying the viscosity of the suspending phase and by the magnitude of the applied gravitational force.
- the thick foam prepared by the method just described was diluted with distilled water to air phase volumes ⁇ of 0.1, 0.01 and 0.001 respectively. After standing for 14 days, gas cell size determinations were made both with a Coulter Counter (aperture size 70 ⁇ m) and a Malvern Zetasizer.
- samples of each of the three amounts of diluted foams were taken after gently shaking and these samples were diluted with distilled water to a dilution suitable for the determination.
- a blank gas cell size determination of distilled water resulted in a total background count from particulate impurities of 600.
- An amount of the original foam was diluted with distilled water to an air phase volume of 0.05 and dialysed against distilled water overnight to reduce the maltodextrin in the liquid phase.
- gas microcells had typical diameters in the range 1 to 10 ⁇ m.
- the microcells could be seen to be freely mobile both in the flowing liquid on the microscope slide and to be moving under the influence of Brownian motion.
- an increased proportion of gas microcells relative to larger cells could be formed.
- the gas cell suspension After dilution to a viscosity which allowed removal of cells larger than the required size (in this case 20 ⁇ m) and separation by creaming, the gas cell suspension had a phase volume of gas of ⁇ 0.4 and contained in the region of 10 9 cells per ml. If required, excess surfactant could be removed by dialysis.
- Gas microcells prepared in this way could be mixed with solutions containing a gelling or a viscosity imparting agent with appropriate yield strength properties to produce a suspension of known phase volume which is substantially stable to creaming of the cells. With suitable microbiological precautions the gas cell suspension remained unchanged over a period of many weeks.
- Gas microcells have been prepared using a mixture of two types of surfactants having different head group sizes but the same or very similar saturated hydrophobic chains.
- This experiment illustrates that microcells of substantial stability can be prepared by the addition of various amounts of co-surfactant(s) in which the characteristic surface dome features can be expanded such that the radius of the dome is modified to become more (or less) similar to that of the gas cell surface.
- This can be illustrated by transmission electron micrograph ( Figure 4).
- the sample was prepared by the procedure of Experiment 1 but from a composition of surfactants of sucrose ester (1.3 w/v) and stearic acid (0.07% w/v). In such microcells the regular pattern is disturbed. Whilst the cell surface remains curved and separated into domains, these are no longer regular.
- PC phosphatidylcholine
- a phase volume of typically 0.7 was obtained in the initial aeration step. After ageing for 24 hours the foam comprising microcells could be stripped of the larger cells by creaming.
- Example 1 The invention is illustrated by Examples 1 and 2 which define skin cream compositions, each containing a preformed gas microcell suspension prepared as described in Experiment 1.
- Example 1
- This example illustrates an oil-in-water skin cream in accordance with the invention.
- Alfol 16RD is cetyl alcohol
- the suncare cream had the following formulation:
- PARSOL 1789 is 4-(1,1-dimethylethyl)-4'- methoxydibenzoylmethane
- PARSOL MCX is octyl methoxycinnamate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
A cosmetic or pharmaceutical composition suitable for topical application comprises stable gas cells having d3,2 average particle size below 20νm.
Description
COSMETIC COMPOSITION
FIELD OF THE INVENTION This invention relates to cosmetic and pharmaceutical compositions, in particular aerated pastes, creams and lotions intended for topical application to the skin, hair, mucosae and teeth. BACKGROUND TO THE INVENTION
A problem encountered with many products, including cosmetic compositions, containing gas cells is the stability with time: this is because a gas cell dispersion comprising large cells is vulnerable to creaming separation of the dispersion into discrete layers of different gas phase volume, the larger cells in the high gas phase volume layer will coalesce through film rupture, while the smaller gas cells, say under 100μm, are unstable with time, due to disproportionation in favour of larger cells and this is in particular true if the gas cells become finer.
US4,588,582 (Lever Brothers Company) discloses modifying the appearance of toothpaste by incorporation therein of 10 to 20% of a gas in the form of discrete bubbles having a diameter in the range of from 10 to 30 microns to give stability.
EP 521 543 describes gas cells dispersed in a continuous liquid medium in a stable condition, ie having a stability in excess of two weeks, the gas cells having a measured d3,2 average diameter of less than 20μm.
The boundary surface of each cell, that is the surface separating the gas of each cell and the rest of the product, is preferably structured and comprises a multitude of adjacent domes. Specific stability is obtained if the
great majority of the domes have hexagonal and some pentagonal outlines. Usually, some irregularities, for example higher polygons, are present amongst the domed structures. These polygons can be of very irregular shape.
In the cases where the surfactant packs in an approximately planar film at the microcell surface, the regular domed surface is absent and may then be smooth or buckled. Gas cells of a good stability with respect to creaming and disproportionation are obtained when the cells have diameters in the range from 0.1 to 20μm and more preferably from 0.5 to 3μm. Diameter throughout this description and claims refers to a measured d3,2 (volume surface) average diameter. The expression "liquid medium" in this description and claims means any medium showing molecule mobility, ie including gels and viscous liquids.
A suitable method of preparing a multitude of gas cells in a liquid medium is also described in EP 521 543 and comprises whipping a liquid medium with a gas such that gas cells of the required dimension are formed while having a surface active agent contained in that liquid medium for stabilising the gas cells. For obtaining the gas cells of the required dimensions sufficient shear should be exerted on the larger gas cells that initially are formed. Factors influencing this shear are the type of mixer or beater or whisk, the viscosity of the liquid medium and the temperature thereof.
In practice a high shear, mixer, such as a Kenwood Chef mixer, a colloid mill, an Oakes mixer, a cavity transfer mixer or a Silverson will be used. By increasing the viscosity and/or lowering the temperature of the liquid medium the size reducing effect of the mixer on the gas cells is increased. If a Kenwood Chef mixer is used at room temperature a suitable dynamic viscosity of the liquid
medium is preferably from 0.1 Pa.s to 20 Pa.s although the range of from 0.2 to 0.4 Pa.s is preferred.
Having obtained the gas cells in the form of a thick creamy foam, this foam is then aged. Stable gas, cells may then be separated from part of the liquid medium used for preparing the cells. Separation can be achieved by centrifuging or using a dialysis membrane after modifying the liquid phase of the gas cell suspension such as by dilution with a miscible fluid.
It has now been found that stable gas cells, prepared as a separate ingredient, for example as described above can advantageously be incorporated into cosmetic and pharmaceutical compositions.
The use of this gas cells ingredient in the compositions of the invention provides improved creaminess in texture, a whiter more opaque product and, dependent on components, enhanced fragrance, flavour, or improved skin or mouthfeel. Having similar particle size to an oil or fat emulsion, suspensions of gas cells prepared as described can be used to replace, or improve on, some of the attributes normally contributed by the oil/fat in cosmetic or pharmaceutical emulsions.
DEFINITION OF THE INVENTION
Accordingly, the invention provides a cosmetic or pharmaceutical composition comprising a preformed gas cells ingredient comprising a surfactant, in which the gas cells have a d3,2 average particle size of less than 20μm and a stability in excess of 2 weeks. DISCLOSURE OF THE INVENTION
The invention is founded on the preparation of an
ingredient comprising a large number of very stable gas cells of very small size. When such cells are present in bulk they will form about 108 to about 1010 per ml. On incorporation of this ingredient into a cosmetic or pharmaceutical composition, it is preferably distributed throughout the mass in the form of discrete cells so as to provide the benefits associated with their presence. However it must be expected that the cells are lilekly to form flocculates in the composition. The stable gas cells, whether present in discrete form or as flocculates, are distinguished from any gas cells of a larger size that may be present. The latter is not in the form of stable cells, but contributes most of the volume. Usually the gas cell number concentration in the composition will be above about 106 per ml, preferably above 107 per ml, with the number and size selected to provide the desired benefit. The particle size of the gas cells is less than 20μm, more preferred 0.1 to 10μm, most preferred from 1 to 6μm.
The gas cells ingredient for use in compositions of the invention have a stability in excess of 2 weeks. With this is meant that upon storage for 2 weeks at 4°C more than 90% by number of the gas cells in the composition still remain intact. Especially preferred are compositions, wherein the stability of the gas cells is more than 4 weeks, most preferably more than 8 weeks.
The gas cells ingredient can be prepared from a cosmetically acceptable surface active material suitable for the making of gas cells with structured surfaces, that is a surfactant whose head group does not carry a substantial charge, compared to that of an ionised anionic or cationic surfactant, and whose head group also occupies a similar surface area to that of the tail group, such that
the tail group is capable of crystallising at the storage temperature of the composition. Preferably, the tail group of the surfactant is saturated and has a carbon chain of at least 14, preferably from 16 to 22 carbon atoms, for products to be held at room temperature or slightly higher. Suitable surfactants are nonionic or virtually so in character, for example mono-, di- or tri-long chain fatty acid esters of sucrose or distearoyl or dipalmitoyl phosphatidylcholine or mixtures thereof.
If desired any suitable thickener may be present in the system while forming the stable gas cells. Suitable thickener materials are for example sugars, (hydroxy-alkyl) celluloses, hydrolysed starches and mixtures thereof.
For preparing compositions containing the gas cells in accordance to the invention, it is desirable to prepare the gas cells in bulk separately and add these as an ingredient to the composition during or after its preparation.
A suitable method of pre-preparing the gas cells ingredient involves the preparation of an aqueous solution of the desired viscosity (for example by using a thickener material at a suitable level) and containing 0.1 to 20 wt% of surfactant (s). In this context it is believed to be within the ability of the skilled person to select those thickeners that will be capable of contributing to the desired viscosity of the aqueous solution. The selection of the surfactant is critical to the subsequent stability of the gas cells. It is restricted to those providing the surface characteristics as described earlier. Gas cells are mechanically incorporated into the aqueous solution and then comminuted by suitable agitation, preferably at high shear, until a system is formed wherein the average particle size of the gas cells is within the limits as herein before described. By taking the appropriate surfactant phase with water or other solutes at low levels,
gas cells according to the invention can if desired "be manufactured without the use of a separate component to contribute the principal part of the viscosity. The cosmetic or pharmaceutical compositions of the invention into which the gas cells are incorporated, as a separate ingredient can be any composition which is suitable for topical application to the skin, hair, mucosae or the teeth. The ingredients of such composition in addition to the gas cells, will be those that are conventionally employed by manufacturers and formulations of cosmetic and pharmaceutical compositions.
According to a particularly preferred embodiment of the invention, the gas cells can be employed to enhance delivery, during topical application, of active materials that can benefit the skin, hair, mucosae or teeth.
For example, it has been shown that co-surfactants containing suitable lipid chains may be incorporated into the structured gas cell surface. In this state, the co surfactant is molecularly dispersed within the interface.
The stable gas cells therefore provide a favourable vehicle both to hold and to deposit beneficial surface active species onto a surface. For example species such as ceramides may be included into and deposited from such structures.
When the composition is in liquid or semi liquid form, the gas cells can be employed to enhance the appearance of the composition. Thus, because of their size (of the order of the wavelength of light) and the refractive index difference between the gas phase and the supporting liquid, gas cells of the present invention scatter light very effectively. Consequently, a concentrated suspension for example, greater than 107 cells ml-1 when present in a suitable support medium can be used as a barrier to light
radiation. Such cells can be used to replace or augment organic sunscreens or solid inorganic pigments, such as ultra fine titanium dioxide, which are currently used in sunscreen creams and lotions.
The amount of gas cells that can usefully be incorporated into compositions in accordance with the invention, as a preformed gas cells ingredient is from 0.001 to 80%, preferably from 0.1 to 10% by volume of the composition.
ILLUSTRATION OF THE GAS CELLS
Accompanying Figures 1 to 6 show electron micrographs of domed and differently structured gas cells which feature in the composition according to the invention, each shown at a different magnification factor.
EXPERIMENTS Experiments 1 to 4 illustrate the preparation of the gas cells ingredient for subsequent incorporation into compositions of the invention.
Experiment 1
An aqueous solution was prepared containing 70% by wt of maltodextrin 63DE and 2% by wt of sucrose mono stearate ester. Using a Kenwood chef mixer this solution was whipped with air for l hour at speed 5. A thick creamy foam resulted.
This foam showed an air phase volume of 0.6 and the great majority of the gas cells had a diameter of the order of 2μm and below. On standing for 40 days little visible change had occurred in these cells.
Electron microscopy photographs showed (see Figures 1 and
2) that the air cells had surfaces compartmentalised into domes, most of the domes having a hexagonal and some pentagonal outline. Few showed a differently polygonal outline: See in particular, Figure 2. A representation showing part of a domed surface and made with the largest magnification factor is shown in Fig 3.
The foam as prepared could be diluted 1000 times with water resulting in a white milky liquid. The same result was obtained on 1000 times dilution with a 30% by wt aqueous maltodextrin 63DE solution. Though no longer suspended/dispersed in a thick viscous aqueous liquid the gas cells with diameters less than 5-10μm remained in suspension, although with some creaming. This creaming could be reversed by simple stirring or swirling. No significant change took place over 20 days.
Even though some flocculation of cells occurred over extended times (normally greater than several days depending on ionic concentration) the cells remained essentially stable with respect to disproportionation. Flocculation did however cause an increase in the rate of creaming of the gas cell suspension. When not flocculated the cells smaller than 10μm can be seen to be strongly under the influence of Brownian motion, showing that the stability of these cells does not result from the cells being constrained in a rigid matrix.
The gas cells could be concentrated again to a gas phase volume of 0.4 by centrifuging the diluted liquid in a centrifuge at a speed of 2500 rpm for 5 minutes. As expected, the rate of concentration of the gas cells by centrifugation could be manipulated by varying the viscosity of the suspending phase and by the magnitude of the applied gravitational force.
The thick foam prepared by the method just described was
diluted with distilled water to air phase volumes Φ of 0.1, 0.01 and 0.001 respectively. After standing for 14 days, gas cell size determinations were made both with a Coulter Counter (aperture size 70μm) and a Malvern Zetasizer.
For the Coulter Counter determination, samples of each of the three amounts of diluted foams were taken after gently shaking and these samples were diluted with distilled water to a dilution suitable for the determination.
The results were as follows:
Phase volume Φ0.1
Phase volume Φ0.1
Phase volume Φ0.1
A blank gas cell size determination of distilled water resulted in a total background count from particulate impurities of 600.
An amount of the original foam was diluted with distilled water to an air phase volume of 0.05 and dialysed against distilled water overnight to reduce the maltodextrin in the liquid phase.
After suitable dilution the following data were obtained for gas cell size distribution using a Malvern Zetasizer.
The same dialysed sample, gently sonicated in an ultrasonic cleaning bath, was subjected to a particle size determination in a Malvern Zetasizer, giving the following data:
These gas cells sizes and distributions are all confirming that the major amount of gas cells is well under10μm size.
Experiment 2
An aqueous solution containing 1.5% (w/w) hydroxy- ethylcellulose and 6% (w/w) sucrose ester, S-1670 Ryoto Sugar Ester ex Mitsubishi Kasei Food Corporation, which is a mixture of predominantly sucrose mono and distearates was aerated in the bowl of a planetary mixer using a fine wire whisk. After 30 minutes the concentration of sucrose esters was increased by 2% by the addition of a more concentrated aqueous solution (25% w/w). Subsequent identical additions were made during whipping at 10 minute intervals until the sucrose ester concentration reached 12% w/w on the total. The overall viscosity of the aerated matrix was maintained approximately constant by the addition of an appropriate amount of water. Optionally, gas cell suspensions prepared in this manner could be processed through a colloid mill to remove quickly the larger gas cells.
Two gas cell suspensions so formed were allowed to stand for 1 hour and subsequently for 1 day. After 100 fold dilutions of both samples no change could be recorded over time in the gas cell size distribution as measured by light microscopy. Observed in this way, gas microcells had typical diameters in the range 1 to 10μm. By light microscopy the microcells could be seen to be freely mobile both in the flowing liquid on the microscope slide and to be moving under the influence of Brownian motion. By increasing the surfactant concentration in this way, an increased proportion of gas microcells relative to larger cells could be formed. After dilution to a viscosity which allowed removal of cells larger than the required size (in this case 20μm) and separation by creaming, the gas cell suspension had a phase volume of gas of ~0.4 and contained
in the region of 109 cells per ml. If required, excess surfactant could be removed by dialysis.
Gas microcells prepared in this way could be mixed with solutions containing a gelling or a viscosity imparting agent with appropriate yield strength properties to produce a suspension of known phase volume which is substantially stable to creaming of the cells. With suitable microbiological precautions the gas cell suspension remained unchanged over a period of many weeks.
Experiment 3
Gas microcells have been prepared using a mixture of two types of surfactants having different head group sizes but the same or very similar saturated hydrophobic chains. This experiment illustrates that microcells of substantial stability can be prepared by the addition of various amounts of co-surfactant(s) in which the characteristic surface dome features can be expanded such that the radius of the dome is modified to become more (or less) similar to that of the gas cell surface. This can be illustrated by transmission electron micrograph (Figure 4). The sample was prepared by the procedure of Experiment 1 but from a composition of surfactants of sucrose ester (1.3 w/v) and stearic acid (0.07% w/v). In such microcells the regular pattern is disturbed. Whilst the cell surface remains curved and separated into domains, these are no longer regular. An otherwise identical preparation, but this time containing 1.3% w/v sucrose ester and 0.7% stearic acid, produced gas microcells containing essentially smooth surfaces with only a few lines or discontinuities separating the curved surfaces. Many cells showed no separate regions. After ageing for 13 days and separation of the microcells by 10 times dilution and removal of the larger cells by creaming, the microcells, in two separate determinations of size distribution gave a d3,2 of 1.19 and
li.25μm for the dispersion. Microcells in these experiments showed stability characteristics analogous to those microcells described above. Experiment 4
Defatted and fully hydrogenated phosphatidylcholine (PC) (98% pure and containing 1% lysophosphatidylcholine plus other phospholipids as impurities (Emulmetic 950 ex Lucas Meyer)) was used in a small scale preparation of gas microcells. 0.5g PC was heated to 65°C in 10g of 60% maltodextrin solution. A homogenous dispersion was prepared by stirring whilst controlling the temperature for 1 hour. Further dispersion using an ultrasonic probe was used in a second run with similar results. The suspension was aerated at room temperature for 1 hour using a microscale whipping apparatus comprising a cage of stainless steel wires driven by a variable speed motor. A phase volume of typically 0.7 was obtained in the initial aeration step. After ageing for 24 hours the foam comprising microcells could be stripped of the larger cells by creaming. The microcells when viewed by transmission electron microscopy had surfaces characterised by the presence of waves or wrinkles (Figure 6) and frequently deviated substantially from an overall spherical (Figure 5). Cells in the range 1 to 20μm could be harvested by standard separation techniques.
EXAMPLES
The invention is illustrated by Examples 1 and 2 which define skin cream compositions, each containing a preformed gas microcell suspension prepared as described in Experiment 1.
Example 1
This example illustrates an oil-in-water skin cream in accordance with the invention.
An oil-in-water cream emulsion having the following formulation was prepared:
% w/w
Mineral oil 4
Gas microcell suspension (Experiment 1) 10
Ceramide 0.01
Brij 56(1) 4
Alfol 16RD(2) 4
Triethanolamine 0.75
Butane-1,3-diol 3
Xanthan gum 0.3
Preservative 0.4
Perfume qs
Butylated hydroxy toluene 0.01
Water to 100
(1) Brij 56 is cetyl alcohol POE (10)
(2) Alfol 16RD is cetyl alcohol
Example 2
This example illustrates a suncare cream in accordance with the invention. The suncare cream had the following formulation:
% w/w
2-hydroxy-n-octanoic acid 1
Gas microcell suspension (Experiment 1) 20
Silicone oil 200 mPas 7.5
Glycerylmonostearate 3
Cetosteryl alcohol 1.6
Polyoxyethylene-(20)-cetyl alcohol 1.4
Xanthan gum 0.5
PARSOL 1789(3) 1.5
PARSOL MCX(4) 7
Perfume qs
Colour qs
Water to 100
(3) PARSOL 1789 is 4-(1,1-dimethylethyl)-4'- methoxydibenzoylmethane (4) PARSOL MCX is octyl methoxycinnamate
Claims
1. A cosmetic or pharmaceutical composition comprising a preformed gas cells ingredient comprising a surfactant, in which the gas cells have a d3,2 average particle size of less than 20μm and a stability in excess of 2 weeks.
2. A composition according to claim 1, wherein the d3,2 average particle size of the gas cells is from 0.1 to 10μm.
3. A composition according to claim 1, wherein the d3,2 average particle size of the gas cells is from 0.5 to 3μm.
4. A composition according to claim 1, 2 or 3, in which the surfactant is chosen from those whose head group does not carry a substantial charge, compared to that of an anionic or cationic surfactant.
5. A composition according to any preceding claim, in which the surfactant is chosen from those whose head group occupies a similar surface area to that of the tail group.
6. A composition according to any preceding claim, in which the surfactant is chosen from those whose tail group is capable of crystallising at the storage temperature of the composition.
7. A composition according to any preceding claim, in. which the tail group has a carbon chain of at least 14 carbon atoms.
8. A composition according to claim 7, in which the carbon chain comprises from 16 to 22 carbon atoms.
9. A composition according to any preceding claim in which the surfactant is a nonionic surfactant.
10. A composition according to any preceding claim, in which the surfactant is a mono-, di-or tri-long chain fatty acid ester of sucrose.
11. A composition according to any of claims 1 to 9, in which the surfactant is chosen from distearoyl phosphatidylcholine, dipalmitoyl phosphatidylcholine and mixtures thereof.
12. A composition according to any preceding claim, in which the preformed gas cells ingredient further comprises a thickener.
13. A composition according to claim 12, in which the thickener is chosen from sugars, (hydroxyalkyl) cellulose, hydrolysed starches and mixtures thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94901923A EP0690708A1 (en) | 1992-12-02 | 1993-11-27 | Cosmetic composition |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92311064 | 1992-12-02 | ||
| EP92311064 | 1992-12-02 | ||
| PCT/EP1993/003358 WO1994012145A2 (en) | 1992-12-02 | 1993-11-27 | Cosmetic composition |
| EP94901923A EP0690708A1 (en) | 1992-12-02 | 1993-11-27 | Cosmetic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0690708A1 true EP0690708A1 (en) | 1996-01-10 |
Family
ID=8211569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94901923A Withdrawn EP0690708A1 (en) | 1992-12-02 | 1993-11-27 | Cosmetic composition |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0690708A1 (en) |
| JP (1) | JPH08503936A (en) |
| AU (1) | AU5629394A (en) |
| CA (1) | CA2150488A1 (en) |
| WO (1) | WO1994012145A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3652549B2 (en) * | 1999-06-14 | 2005-05-25 | 株式会社コーセー | Cosmetics |
| JP4322124B2 (en) * | 2002-03-28 | 2009-08-26 | 伯東株式会社 | Method for stabilizing bubbles in foam-containing cosmetics |
| EP2658638B1 (en) * | 2010-12-28 | 2014-09-03 | Unilever N.V. | Method for production of an emulsion |
| US9193852B2 (en) | 2013-12-27 | 2015-11-24 | L'oreal | Stable aerated compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3141641A1 (en) * | 1981-10-16 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION |
| GB8325954D0 (en) * | 1983-09-28 | 1983-11-02 | Unilever Plc | Paste with entrained gas |
| US4684479A (en) * | 1985-08-14 | 1987-08-04 | Arrigo Joseph S D | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures |
| US5219538A (en) * | 1987-03-13 | 1993-06-15 | Micro-Pak, Inc. | Gas and oxygen carrying lipid vesicles |
| DE3741201A1 (en) * | 1987-12-02 | 1989-06-15 | Schering Ag | ULTRASONIC PROCESS AND METHOD FOR IMPLEMENTING IT |
| CH674804A5 (en) * | 1988-02-05 | 1990-07-31 | Battelle Memorial Institute | Homogeneous stale cosmetic cream as light foam - contains dispersed fine bubbles of air or inert gas |
| IN172208B (en) * | 1990-04-02 | 1993-05-01 | Sint Sa | |
| JP3247374B2 (en) * | 1990-10-05 | 2002-01-15 | ブラッコ インターナショナル ベスローテン フェンノートシャップ | A method for the production of stable suspensions of hollow gas-encapsulated microspheres suitable for ultrasound ecology |
| GB9111880D0 (en) * | 1991-06-03 | 1991-07-24 | Unilever Plc | Forming minute gas cells in a liquid medium |
-
1993
- 1993-11-27 WO PCT/EP1993/003358 patent/WO1994012145A2/en not_active Ceased
- 1993-11-27 EP EP94901923A patent/EP0690708A1/en not_active Withdrawn
- 1993-11-27 AU AU56293/94A patent/AU5629394A/en not_active Abandoned
- 1993-11-27 CA CA 2150488 patent/CA2150488A1/en not_active Abandoned
- 1993-11-27 JP JP6512784A patent/JPH08503936A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9412145A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5629394A (en) | 1994-06-22 |
| JPH08503936A (en) | 1996-04-30 |
| CA2150488A1 (en) | 1994-06-09 |
| WO1994012145A2 (en) | 1994-06-09 |
| WO1994012145A3 (en) | 1994-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69433386T2 (en) | Propylene glycol stearate vesicles | |
| US5976604A (en) | Oil-in-water emulsion composition having high oil content and method for producing the same | |
| CA2110493C (en) | Gas cells in a liquid medium | |
| JPH08245338A (en) | Acidic composition based on lipid vesicles and method of use thereof | |
| Förster et al. | Emulsification by the phase inversion temperature method: the role of self‐bodying agents and the influence of oil polarity | |
| CN1845720B (en) | Concentrated and diluted stable oil-in-water emulsion | |
| CA2150687C (en) | Frozen confections | |
| CA2175471C (en) | Sucrose distearate lipid vesicles | |
| JP4820002B2 (en) | Glucosid pouch lamella vesicle | |
| Tadros | Colloid aspects of cosmetic formulations with particular reference to polymeric surfactants | |
| WO1994012145A2 (en) | Cosmetic composition | |
| JPS586530B2 (en) | composite emulsion | |
| EP0667767B1 (en) | Method for the preparation of creams | |
| JPH0899853A (en) | Skin cosmetic | |
| JP2001354515A (en) | Composite emulsion and cosmetic formulated with the same | |
| JPH0532522A (en) | Cosmetic manufacturing method and cosmetic additive | |
| JPH09294927A (en) | High oil content oil-in-water emulsion composition and method for producing the same | |
| JPH09239258A (en) | Membrane composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19950530 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): CH DE ES FR GB IT LI NL SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19960601 |